Seagen Inc.(NASDAQ : SGEN)
Volume Open Day's Low Day's High 52 Wk Low 52 Wk High Bid Ask EPS PE Ratio Shares Market Cap Dividend Ex-Div Date Yield
Daily Pre-Market Movers
Receive our daily pre-market mover email, free.
Health Technology » Pharmaceuticals Major
|JNJ||Johnson & Johnson||-0.60%||163.54||0.7%||$1305.95m|
|LLY||Eli Lilly & Co.||-1.93%||323.65||1.1%||$1056.02m|
|BMY||Bristol-Myers Squibb Co.||-0.82%||71.12||1.0%||$763.08m|
|MRK||Merck & Co., Inc.||-0.52%||86.19||0.7%||$687.90m|
|ALNY||Alnylam Pharmaceuticals, Inc.||-4.41%||200.16||8.2%||$210.64m|
|GBT||Global Blood Therapeutics, Inc.||0.04%||68.10||5.4%||$190.73m|
|BHVN||Biohaven Pharmaceutical Holding Co. Ltd.||-0.21%||151.22||0.0%||$178.64m|
|IDXX||IDEXX Laboratories, Inc.||-1.81%||325.80||3.9%||$175.84m|
|HZNP||Horizon Therapeutics Plc||-1.28%||61.89||5.4%||$160.55m|
|NVO||Novo Nordisk A/S||-0.74%||99.65||0.1%||$140.44m|
Seagen Inc. is a biotechnology company, which engages in the development and commercialization of antibody-based therapies for the treatment of cancer. Its products include Adcetris and Padcev. The firm is also advancing a pipeline of novel therapies for solid tumors and blood-related cancers. The company was founded by Clay B. Siegall and H. Perry Fell on July 15, 1997, and is headquartered in Bothell, WA.